MiMedx Group, Inc. (NASDAQ:NASDAQ:MDXG) Q1 2022 Earnings Conference Call May 04, 2022, 08:30 AM ET Company Participants Jack Howarth - Senior Vice President, Investor Relations Tim Wright -.
Operator
Good day ladies and gentlemen and welcome to Oncternal s Therapeutics Inc. first-quarter 2021 financial results call. [Operator instructions] At this time it is my pleasure to turn the floor over to your host Richard Vincent. Sir the floor is yours.
Rich Vincent
Chief Financial Officer
Thank you, Melinda. Good afternoon, everyone, and thank you for joining us today. Joining me on the call this afternoon are our president and CEO, Dr. James Breitmeyer; and our acting CMO, Dr.
Edwina Baskin-Bey. We welcome all of you. Today s call includes a business update and discussion of our 2021 first-quarter financial results which will be followed by Q&A. Today s press release and replay of today s earnings call will be available on the Investor Relations section of Oncternal s website for at least the next 30 days.
vTv Therapeutics (VTVT) Gets a Buy Rating from Northland Securities markets.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from markets.co Daily Mail and Mail on Sunday newspapers.